Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Share Buyback Programme

10 Apr 2025 07:01

RNS Number : 4134E
Treatt PLC
10 April 2025
 

10 April 2025

Treatt PLC

("Treatt" or the "Company")

Share Buyback Programme

Launch of Share Buyback Programme

Treatt PLC, the manufacturer and supplier of natural ingredients for the beverage, flavour and fragrance industries, is pleased to announce it will commence a share buyback programme (the "Share Buyback Programme"), as referenced in the Company's trading update released today.

Treatt has a strong balance sheet and the Board has considered the Share Buyback Programme as part of the Company's capital allocation framework, whilst also reflecting Treatt's strong cash performance together with the Board's confidence in Treatt's strategy and medium term outlook.

Details of the Share Buyback Programme

The Company has appointed its corporate brokers, Investec Bank plc ("Investec") and Peel Hunt LLP ("Peel Hunt") (together, the "Brokers"), to manage the share buyback programme to repurchase ordinary shares of 2 pence each in the capital of the Company (the "Ordinary Shares") on the Company's behalf from 10 April 2025, for a maximum aggregate consideration of £5 million (the "Buyback Amount"). The Share Buyback Programme will run until the earlier of the Buyback Amount being utilised in the repurchase of Ordinary Shares or the expiry of the 2025 Authority (defined below). Shares repurchased will be held in treasury at the Company's discretion for later reissue or cancellation.

Treatt has given irrevocable and non-discretionary instruction to Investec and Peel Hunt to conduct the Share Buyback Programme on its behalf. The Brokers will act as "riskless" or "matched" principals for the purposes of the Share Buyback Programme, within certain parameters, and will make trading decisions concerning the purchases of Ordinary Shares independently of the Company.

Shares purchased under the Share Buyback Programme will take place in open market transactions and in accordance with the general authority to purchase Ordinary Shares granted to the directors of the Company by its shareholders at the Company's annual general meeting in 2025 (the "2025 Authority"). The maximum number of Ordinary Shares which the Company is authorised to purchase under the 2025 Authority is 6,120,976. In accordance with the 2025 Authority, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is an amount equal to the higher of (i) 5% above the average of the middle market quotations for an Ordinary Share as derived from the London Stock Exchange Daily Official List on the five business days immediately preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest current independent bid for Ordinary Shares on the trading venue where the purchase is carried out. Furthermore, in accordance with the 2025 Authority, the minimum price which may be paid for each Ordinary Share is 2 pence, being the nominal value of an Ordinary Share. The Share Buyback Programme will be conducted in accordance with Article 5(1) of Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR") and the provisions of Commission Delegated Regulation (EU) 2016/1052, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), which deal with buyback programmes. The Share Buyback Programme will also be conducted in accordance with Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Treatt will make further regulatory announcements in respect of repurchases of Ordinary Shares as required.

 

For further information, please contact:

 

Treatt PLC

David Shannon, Chief Executive Officer

Ryan Govender, Chief Financial Officer

 

+44 (0) 1284 702500

Investec Bank Plc - Joint Corporate Broker

+44 (0) 20 7597 5970

Patrick Robb

David Anderson

Shalin Bhamra

 

Peel Hunt LLP - Joint Corporate Broker

+44 (0) 20 7418 8900

George Sellar

Andrew Clark

Finn Nugent

 

MHP - Financial PR

+44 (0) 20 3128 8100

Tim Rowntree

Eleni Menikou

Veronica Farah

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSEFUEISEIL
Date   Source Headline
30th Mar 20177:00 amRNSTrading Statement
27th Mar 20179:30 amRNSHolding(s) in Company
24th Mar 20173:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:50 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
23rd Feb 20177:00 amRNSTrading Statement
20th Feb 20174:03 pmRNSDirector/PDMR Shareholding
14th Feb 20178:15 amRNSHolding(s) in Company
10th Feb 20179:41 amRNSHolding(s) in Company
1st Feb 20172:19 pmRNSDirector/PDMR Shareholding
30th Jan 20175:58 pmRNSNotification of a Transaction of a Director
27th Jan 20174:42 pmRNSResult of AGM
27th Jan 20177:15 amRNSTrading Statement
30th Dec 20167:00 amRNSAnnual Information Update
30th Dec 20167:00 amRNSTotal Voting Rights
22nd Dec 20163:11 pmRNSUpdate on Site Relocation
20th Dec 201610:26 amRNSDirector/PDMR Shareholding
13th Dec 20161:11 pmRNSNotification of Transactions of Directors
9th Dec 20163:05 pmRNSAnnual Financial Report
5th Dec 20164:35 pmRNSBlock listing Interim Review
1st Dec 20162:55 pmRNSVoting Rights and Capital
29th Nov 20167:00 amRNSFinal Results
31st Oct 20164:45 pmRNSDirector/PDMR Shareholding
19th Oct 20162:51 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTrading Update
29th Sep 20161:21 pmRNSTotal Voting Rights
27th Sep 20163:24 pmRNSHolding(s) in Company
22nd Sep 20163:36 pmRNSDirector/PDMR Shareholding
6th Sep 20163:04 pmRNSHolding(s) in Company
5th Sep 201610:41 amRNSHolding(s) in Company
1st Sep 20163:00 pmRNSDirector/PDMR Shareholding
3rd Aug 201611:00 amRNSDirector/PDMR Shareholding
2nd Aug 20169:54 amRNSTR-1: Notification of Major Interest In Shares
19th Jul 20167:00 amRNSUpdate on Earthoil earn-out dispute
15th Jul 201611:57 amRNSDirector/PDMR Shareholding
17th Jun 201612:48 pmRNSDirector/PDMR Shareholding
15th Jun 20163:26 pmRNSDirector/PDMR Shareholding
13th Jun 20163:53 pmRNSDirector/PDMR Shareholding
9th Jun 20165:07 pmRNSDirector/PDMR Shareholding
3rd Jun 20163:05 pmRNSBlock Listing Six Monthly Return
26th May 20165:09 pmRNSDirector/PDMR Shareholding
24th May 201612:09 pmRNSDirector/PDMR Shareholding
20th May 201611:46 amRNSDirector/PDMR Shareholding
17th May 20167:00 amRNSHalf-year Report
13th May 20163:24 pmRNSBoard Appointment
29th Apr 20169:19 amRNSTotal Voting Rights
28th Apr 20162:19 pmRNSDirector/PDMR Shareholding
13th Apr 20168:34 amRNSDirector/PDMR Shareholding
12th Apr 20162:37 pmRNSDirector/PDMR Shareholding
1st Apr 20167:26 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.